Ligand validation:6A3W

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 6A3W designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6A3W_NAG_I_201	4%	78%	0.23	0.595	0.31	0.58	-	-	0	0	100%	0.9333
6A3V_NAG_D_301	25%	83%	0.201	0.839	0.31	0.46	-	-	0	0	100%	0.9333
6CU0_NAG_H_501	20%	47%	0.197	0.798	0.76	1.26	1	3	0	0	100%	0.9333
6CPR_NAG_F_501	19%	69%	0.253	0.846	0.34	0.84	-	-	0	0	100%	0.9333
6MI2_NAG_C_201	18%	78%	0.209	0.795	0.35	0.53	-	-	0	0	100%	0.9333
8GYE_NAG_A_201	17%	85%	0.236	0.815	0.31	0.43	-	-	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
5O59_NAG_B_501	100%	68%	0.024	0.991	0.38	0.86	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.